Dr. Roy Brower, professor in the Division of Pulmonary & Critical Care Medicine, will step down as director of the Johns Hopkins Hospital Medical Intensive Care Unit (MICU) on July 1, 2021 after 33 years of unwavering leadership and dedicated service. Under his leadership, the MICU has become a renowned center for cutting-edge clinical research that has transformed patient care.
Dr. Brower was one of the pioneers in the implementation of rigorous, protocol driven multicenter trials in the ICU, particularly the use of lung protective mechanical ventilation for patients with acute respiratory distress syndrome (ARDS). The demonstration of the importance and subsequent implementation of lung protective ventilation strategies may be the single greatest factor in the improved outcomes and survival among patients with ARDS and respiratory failure. In 2015, he received the American Thoracic Society (ATS) Lifetime Achievement Award from the Critical Care Assembly. He also received a Presidential Citation from the Society of Critical Care Medicine and a Presidential Commendation from the ATS.
Dr. Brower will continue to supervise the critical care advanced practice providers, chair the steering committee of the current NHBLI-funded PETAL ARDS clinical trials network, attend in the MICU and mentor JHU faculty, fellows and medical students.
Dr. David Hager, associate professor in the Division of Pulmonary & Critical Care Medicine, will assume the role of director of the JHH MICU. Dave has humbly served as associate medical director of the MICU since 2011, and director of the intermediate care unit. He has consistently identified opportunities to improve standards of care and has been awarded numerous teaching awards, including the Pulmonary and Critical Care Fellows Teaching Award. He has shown immense dedication leading efforts aimed at not only providing, but improving clinical care of critically ill patients at JHU.
